| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2773701 | Endocrinología y Nutrición | 2013 | 5 Pages |
Abstract
Intravenous glucocorticoid therapy decreased activity in patients with moderate to severe active GO, with major improvement occurring in diplopia, eye pain, and exophthalmos. Side effects were mild and uncommon. Treatment response was independent from the underlying disease, prior radioiodine treatment, or smoking status.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
MarÃa Rosa Alhambra Expósito, MarÃa Ángeles Gálvez Moreno, Paloma Moreno Moreno, Inmaculada Prior Sánchez, Concepción Muñoz Jiménez, Pedro Benito López,